Search Results Search Sort by RelevanceMost Recent Personal Narrative Jun 2019 PrEP and the Judgment of Prevention Samuel Dubin Prevention efforts can marginalize patients by stigmatizing certain behaviors, so distinguishing individual professionals’ preferences about those behaviors is critical. AMA J Ethics. 2019;21(6):E536-539. doi: 10.1001/amajethics.2019.536. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138. Policy Forum Feb 2019 What Are Important Ethical Implications of Using Facial Recognition Technology in Health Care? Nicole Martinez-Martin, JD, PhD Applications can identify and monitor patients. They can also diagnose genetic, medical, and behavioral conditions. AMA J Ethics. 2019;21(2):E180-187. doi: 10.1001/amajethics.2019.180. Case and Commentary Feb 2020 How Should Vaccine Campaigns Balance Need for Clear Communication Against Need for Timely Administration of Large-Scale Programs? Paul Ndebele, PhD and Sithembile Ruzario, MSc Limited understanding of disease etiology often leads to resistance, which can result in low vaccine uptake. AMA J Ethics. 2020;22(2):E76-81. doi: 10.1001/amajethics.2020.76. Personal Narrative Feb 2020 Six Tips for Giving Good Health Care to Anyone With a Cervix Ryan K. Sallans, MA Eliminating cervical cancer inequality means transmen need regular, unimpeded access to regular Pap screening. AMA J Ethics. 2020;22(2):E168-175. doi: 10.1001/amajethics.2020.168. Podcast Feb 2020 Ethics Talk: Providing Compassionate Care for Transmen Author Ryan Sallans discusses his experience accessing health care and suggests how to take good gynecological care of transmen. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Personal Narrative Jun 2019 PrEP and the Judgment of Prevention Samuel Dubin Prevention efforts can marginalize patients by stigmatizing certain behaviors, so distinguishing individual professionals’ preferences about those behaviors is critical. AMA J Ethics. 2019;21(6):E536-539. doi: 10.1001/amajethics.2019.536.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Feb 2019 How Should Clinicians Communicate With Patients About the Roles of Artificially Intelligent Team Members? Daniel Schiff, MS and Jason Borenstein, PhD Clinical applications of AI prompt consideration of how responsibility should be distributed among professionals, tech companies, and others. AMA J Ethics. 2019;21(2):E138-145. doi: 10.1001/amajethics.2019.138.
Policy Forum Feb 2019 What Are Important Ethical Implications of Using Facial Recognition Technology in Health Care? Nicole Martinez-Martin, JD, PhD Applications can identify and monitor patients. They can also diagnose genetic, medical, and behavioral conditions. AMA J Ethics. 2019;21(2):E180-187. doi: 10.1001/amajethics.2019.180.
Case and Commentary Feb 2020 How Should Vaccine Campaigns Balance Need for Clear Communication Against Need for Timely Administration of Large-Scale Programs? Paul Ndebele, PhD and Sithembile Ruzario, MSc Limited understanding of disease etiology often leads to resistance, which can result in low vaccine uptake. AMA J Ethics. 2020;22(2):E76-81. doi: 10.1001/amajethics.2020.76.
Personal Narrative Feb 2020 Six Tips for Giving Good Health Care to Anyone With a Cervix Ryan K. Sallans, MA Eliminating cervical cancer inequality means transmen need regular, unimpeded access to regular Pap screening. AMA J Ethics. 2020;22(2):E168-175. doi: 10.1001/amajethics.2020.168.
Podcast Feb 2020 Ethics Talk: Providing Compassionate Care for Transmen Author Ryan Sallans discusses his experience accessing health care and suggests how to take good gynecological care of transmen.